rts logo

Sonoma Pharmaceuticals Inc. (SNOA) Volatility At 35.52%, Should You Add A Position?

Sonoma Pharmaceuticals Inc. (NASDAQ: SNOA) is 6.15% higher on its value in year-to-date trading and has touched a low of $2.32 and a high of $18.20 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The SNOA stock was last observed hovering at around $4.30 in the last trading session, with the day’s loss setting it -0.47%.

Currently trading at $3.83, the stock is 2.05% and -28.11% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.28 million and changing -10.93% at the moment leaves the stock -3.27% off its SMA200. SNOA registered -78.24% loss for a year compared to 6-month gain of 39.99%.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The stock witnessed a -21.06% loss in the last 1 month and extending the period to 3 months gives it a -6.13%, and is 20.82% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 35.52% over the week and 20.24% over the month.

Sonoma Pharmaceuticals Inc. (SNOA) has around 172 employees, a market worth around $3.94M and $12.70M in sales. Profit margin for the company is -35.91%. Distance from 52-week low is 65.23% and -78.95% from its 52-week high. The company has generated returns on investments over the last 12 months (-90.55%).

The EPS is expected to grow by 55.81% this year

18.0 institutions hold shares in Sonoma Pharmaceuticals Inc. (SNOA), with institutional investors hold 2.18% of the company’s shares. The shares outstanding are 1.03M, and float is at 1.00M with Short Float at 37.62%. Institutions hold 2.14% of the Float.

The top institutional shareholder in the company is CITADEL ADVISORS LLC with over 0.2 million shares valued at $41412.0. The investor’s holdings represent 1.2504 of the SNOA Shares outstanding. As of 2024-06-30, the second largest holder is GEODE CAPITAL MANAGEMENT, LLC with 86644.0 shares valued at $18385.0 to account for 0.5551 of the shares outstanding. The other top investors are JANE STREET GROUP, LLC which holds 45295.0 shares representing 0.2902 and valued at over $9611.0, while STATE STREET CORP holds 0.1558 of the shares totaling 24315.0 with a market value of $5160.0.

Related Posts